Trial site
Finlay Medical Research
- 10running trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Mild cognitive impairment2 trials
- Asthma1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Obesity1 trial
- Stroke1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting9 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Acumen Pharmaceuticals1 trial
- Amgen1 trial
- Eisai Inc.1 trial
- Novartis Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Active, not recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Active, not recruiting
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026